Author

P. Gordts

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 3 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:metabolism & bioenergetics· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. Chou· 1 shared A. Cuenca· 1 shared A. Majithia· 1 shared A. Pessentheiner· 1 shared A. R. Harrington· 1 shared B. Ramms· 1 shared C. Metallo· 1 shared C. Nora· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Chou

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Host-derived oxidized phospholipids initiate effector-triggered immunity fostering lethality upon microbial encounter.

M. Di Gioia, V. Poli, P. Tan, R. Spreafico, A. Chou, A. Cuenca, P. Gordts, L. Pandolfi, F. Meloni, J. Witztum, J. Chou, J. Springstead, I. Zanoni

The paper shows host-derived oxidized phospholipids initiate effector-triggered immunity, leading to lethality upon microbial encounter, and demonstrates that blocking oxPLs reduces inflammation and host death.

bioRxiv · Nov 21, 2023 · PreprintImmunology

Glycocalyx engineering with heparan sulfate mimetics attenuates Wnt activity during adipogenesis to promote glucose uptake and metabolism.

G. Trieger, A. Pessentheiner, S. Purcell, C. R. Green, N. DeForest, K. Willert, A. Majithia, C. Metallo, K. Godula, P. Gordts

Journal of Biological Chemistry · May 1, 2023Peer-reviewedCell Biology

Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity

B. Ramms, D. P. Pollow, H. Zhu, C. Nora, A. R. Harrington, I. Omar, P. Gordts, M. Wortham, M. Sander

This study shows that systemic LSD1 inhibition reduces obesity-related metabolic issues like NAFLD and improves insulin sensitivity in mice without affecting lean mice.

bioRxiv · Nov 25, 2021Physiology